Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 6:49 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1657–1680 of 3,253 matching trials from the live ClinicalTrials.gov search.

Filters: Not yet recruiting Clear all

Conditions: Dry Eye, Evaporative Dry Eye, Evaporative Dry Eye Disease
Interventions: acoltremon 0.003%.; Drug
Lead sponsor: Southern College of Optometry; Other
Eligibility: 18 Years and older
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Alcohol Use Disorder, Insomnia
Interventions: Daridorexant, Placebo, Brief Counseling, MEMS and Medication Accounting, Contingency Management for Medication Adherence; Drug · Behavioral · Device
Lead sponsor: Sterling McPherson; Other
Eligibility: 18 Years and older
Enrollment: 205 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Spokane, Washington

Conditions: Influenza
Interventions: cH15/3, cH4/3, cH5/1N1, cH8/1N1, Saline; Biological · Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 59 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Pre-eclampsia, Pregnancy, Post Partum
Interventions: Not listed
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Tooth Discoloration, Dentin Sensitivity, Patient Satisfaction
Interventions: BLEACHING GEL A, 5% NF_TiO2, BLEACHING GEL B, VISIBLE LIGHT IRRADIATION, Whiteness HP 35%, Whiteness HP Automixx 6%; Device · Radiation
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 65 Years
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Reintegration Into Civilian Life
Interventions: Health Coaching, Enhanced treatment as usual; Behavioral · Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 398 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Kidney Transplant Recipient, Cutaneous Squamous Cell Carcinoma (CSCC), Advanced Cutaneous Squamous Cell Carcinoma, Kidney Transplant
Interventions: Cemiplimab, Prednisone, Sirolimus, Cetuximab (EGFR inhibitor); Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Psilocybin Intoxication
Interventions: 0mg Psilocybin Capsule + 0.00% BAC Alcoholic Drink, 1mg Psilocybin Capsule + 0.00% BAC Alcoholic Drink, 5mg Psilocybin Capsule + 0.00% BAC Alcoholic Drink, 15mg Psilocybin Capsule + 0.00% BAC Alcoholic Drink, 25mg Psilocybin Capsule + 0.00% BAC Alcoholic Drink, 0mg Psilocybin Capsule + 0.08% BAC Alcoholic Drink; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 21 Years and older
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Diabetes Mellitus ( Type 1 and Type 2), Hypertension
Interventions: Guide My Care Tool; Other
Lead sponsor: Fitbit LLC; Industry
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Aging
Interventions: Calf muscle strengthening; Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 65 Years to 80 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Cesarean Delivery, Cesarean Section, Pain, Postoperative, Opioid Consumption, Postoperative
Interventions: Suzetrigine, Placebo; Drug
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years and older · Female only
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Obesity, Overweight
Interventions: LY4247147, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: Lenexa, Kansas • Salt Lake City, Utah

Conditions: Intractable Pain, Palliative Care
Interventions: Resiniferatoxin; Drug
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 99 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Ovarian Cancer, Genetic Testing, Genetic Counseling
Interventions: Genetic testing education video; Behavioral
Lead sponsor: Rachel Miller; Other
Eligibility: 18 Years and older · Female only
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Arthroplasty, Replacement, Shoulder, Arthritis Shoulder, Rotator Cuff Arthropathy
Interventions: Not listed
Lead sponsor: Vani Sabesan; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 5
States / cities: Atlantis, Florida • North Liberty, Iowa • Leawood, Kansas + 2 more

Conditions: Acute Kidney Injury (AKI)
Interventions: PRECISE-AKI Clinical Decision Support Tool; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2028 – 2029
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Turner Syndrome, Primary Ovarian Insufficiency
Interventions: Estradiol transdermal patch 0.025mg/24 hours- 1/8th fractionated patch; Drug
Lead sponsor: Children's National Research Institute; Other
Eligibility: 8 Years to 12 Years · Female only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: PAD, PAD - Peripheral Arterial Disease
Interventions: Lower-Extremity Heat Therapy, Sham Lower-Extremity Heat Therapy; Device
Lead sponsor: Aquilo Sports, LLC; Industry
Eligibility: 50 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Cancer, Cancer Diagnosis
Interventions: GRAIL Galleri MCED test; Device
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 22 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Lennox-Gastaut Syndrome
Interventions: Cannabidiol Oral Solution; Drug
Lead sponsor: Jazz Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 3
States / cities: Fresno, California • New Orleans, Louisiana • Raleigh, North Carolina

Conditions: Heart Failure, Acute Decompensated Heart Failure
Interventions: Early Discharge with Lasix® ONYU (furosemide injection, for subcutaneous use) using SQIN-Infusor; Combination Product
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 100 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2028
U.S. locations: 2
States / cities: Dallas, Texas

Conditions: Multiple Chronic Conditions, Shared Decision-making
Interventions: MyHP-South Program; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Depression
Interventions: Mothers and Babies, Mothers and Babies Down Syndrome; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Cashew Nut Allergy, Tree Nut Allergies
Interventions: Cashew sublingual immunotherapy, Placebo sublingual immunotherapy; Drug
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 1 Year to 11 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Search by objective public record fields.

Evaporative Dry Eye

Daridorexant for People With Insomnia and Alcohol Use Disorder Study

Safety and Immunogenicity of Chimeric Hemagglutinin mRNA Vaccine Candidates

Gestational Changes in Hemodynamics and Respiratory Mechanics in Association With Pre-Eclampsia

Efficacy and Safety Assessment of Experimental Bleaching Agents

Health Coaching and Veteran Reintegration

Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma

The Impact of Dose on the Impairing, Intoxicating, and Abuse-Related Effects of Psilocybin

Care COMPASS Study

IMAT Quality in Aging

Suzetrigine for Opioid-Free Recovery After Cesarean Delivery

A Study of LY4247147 in Participants With Obesity or Overweight Who Are Otherwise Healthy

Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain

PITCH - Impacting Hereditary Cancer Testing

Three Year Outcomes After Shoulder Arthroplasty

Precision-Medicine Diagnostic Support in Hospitalized Veterans With Acute Kidney Injury

Pre-pubertal Low Dose Transdermal Estradiol in Turner Syndrome

Home-Based Lower-Extremity Heat Therapy for Walking Function in Peripheral Artery Disease

The DISCOVER Study

A Study to Investigate the Effect of Gradual Titration to Optimize Cannabidiol Treatment in Adults With LGS

Early Discharge With Subcutaneous Furosemide Versus Standard Care in Acute Heart Failure

"My Health Priorities" Program for Rural and Underserved Older Adults With Multiple Chronic Conditions (MyHP-South)

Co-Designing and Evaluating Additional Mothers and Babies Program Content for Expectant and New Parents of Children With Down Syndrome

UNC Cashew Sublingual Immunotherapy